Over the past three months, Verastem Inc. [VSTM] ended the trading day at $2.27 and exhibited a change of 7.08% with a 24 hour trading and reached upto the volume of 3.23M compared to its recorded trading volume of 7.61 million. VSTM generated a 1 year amount change with 65.69%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by 33.53% with an amount shift of 84.55% over the last month.
On 30, November 2020, Verastem Oncology Initiates Phase 2 Registration-Directed Trial of VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer. According to news published on Yahoo Finance, Previous Data from Investigator-Initiated Phase 1/2 Trial Show Encouraging Response Rates, Durability and a Favorable Safety Profile.
Analyst Birdseye View:
The most recent analyst activity for Verastem Inc. [NASDAQ:VSTM] stock was on May 10, 2019, when it was Downgrade with a Mkt perform rating from Raymond James. On July 13, 2018, BTIG Research Initiated a Buy rating and boosted its price target on this stock to $17. On May 02, 2018, Seaport Global Securities Initiated a Buy rating and increased its price target to $14. On March 08, 2018, B. Riley FBR Inc. Initiated a Buy rating and increased its price target to $15. On September 07, 2017, H.C. Wainwright Reiterated a Buy rating and boosted its amount target on this stock to $10. On April 13, 2017, Oppenheimer Initiated an Outperform rating. H.C. Wainwright elevated its amount target by recapitulating a higher weight for this stock.
In the past 52 weeks of trading, this stock has oscillated between a low of $1.08 and a peak of $4.67. Right now, the middling Wall Street analyst 12-month amount mark is $3.00. At the most recent market close, shares of Verastem Inc. [NASDAQ:VSTM] were valued at $2.27.
Verastem Inc. [NASDAQ:VSTM] most recently reported quarterly sales of 8.65 billion, which represented growth of 773.30%. This publicly-traded organization’s revenue is $129,304 per employee, while its income is -$1,105,252 per employee. This company’s Gross Margin is currently 63.70%, its Operating Margin is -71.90%, its Pretax Margin is -854.77, and its Net Margin is -854.77. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -70.67, -226.98, -73.63 and -84.46 respectively.
The Principal structure of this organization shows its whole liability to whole principal at 93.75 and the whole liability to whole assets at 74.14. It shows enduring liability to the whole principal at 93.38 and enduring liability to assets at 0.74 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 2.12 points at 1st support level, the second support level is making up to 1.97. But as of 1st resistance point, this stock is sitting at 2.36 and at 2.45 for 2nd resistance point.
Verastem Inc. [VSTM] reported its earnings at $0.08 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.04/share signifying the difference of 0.04 and 100.00% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.14 calling estimates for -$0.15/share with the difference of 0.01 depicting the surprise of 6.70%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Verastem Inc. [NASDAQ:VSTM] is 5.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.53. Now if looking for a valuation of this stock’s amount to sales ratio it’s 5.72 and it’s amount to book ratio is 14.97.
The most recent insider trade was by RA CAPITAL MANAGEMENT, L.P., 10% Owner, and it was the sale of 1.16 million shares on Jun 25. RA CAPITAL MANAGEMENT, L.P., the 10% Owner, completed a sale of 1.3 million shares on Apr 27.